Cholera Vaccines Market Size, Industry Share, Trends, Analysis, Report, Segments, Demand and Forecast by 2022-2027

2022-03-22 06:15:08 UTC | Business, Economy, Finances, Banking & Insurance
Cholera Vaccines Market Size, Industry Share, Trends, Analysis, Report, Segments, Demand and Forecast by 2022-2027

According to the latest report by IMARC Group, titled "Global Cholera Vaccines Market Size, Share, Industry Trends, Growth, Opportunity and Forecast 2022-2027", The global cholera vaccines market reached a value of US$ XX Billion in 2021. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2022-2027.

Cholera is a bacterial infection caused by the bacterium Vibrio Cholera that spreads through the contaminated food and water consumption. It is an intestinal disease that exhibits the symptoms of severe diarrhea, abdominal pain, muscle cramps, dry mucus, and dehydration, which may lead to death in extreme cases. As a result, it is essential to control cholera through vaccination, available in the form of inactivated and live oral cholera vaccines. Cholera vaccine is particularly administered to travelers and people living in cholera affected areas, which helps develop immunity against the disease.

Report Metric

Historical: 2016-2021

Base Year: 2021

Forecast Year: 2022-2027


Cholera Vaccines Market Trends and Drivers:

The global cholera vaccines market is primarily driven by the increasing prevalence of cholera worldwide as it is deemed a global threat to public health, especially in regions lacking social development.


Request a Free PDF Sample for more detailed market insights: 
https://www.imarcgroup.com/cholera-vaccines-market/requestsample

Besides this, the growing awareness regarding the lack of proper sanitation and the adverse effects of consuming contaminated food are also fueling the market growth. In addition, governments in various countries are implementing initiatives to support cholera preventive care by focusing on immunization programs and extensively investing in developing novel cholera vaccines.


Furthermore, non-governmental organizations (NGOs) are increasing awareness about cholera to reduce vaccine-preventable diseases. Moreover, the rising research and development (R&D) activities to enhance the efficacy and cost-effectiveness of vaccines is further expected to propel the market growth in the upcoming years.


Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

 

Global Cholera Vaccines Market 2022-2027 Analysis and Segmentation:

 
Competitive Landscape:

 
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

 
Astellas Pharma Inc., Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.), Emergent BioSolutions Inc., Eubiologics Co. Ltd., Johnson & Johnson, Merck & Co. Inc, Pfizer Inc., PharmaChoice Canada Inc, Sanofi S.A., Takeda Pharmaceutical Company Limited and Valneva SE.

The report has segmented the market on the basis of region, vaccine type, product and end user.


Breakup by Vaccine Type:

·         Whole Cell V. Cholerae O1 with Recombinant B-Subunit

·         Killed Oral O1 and O139
 

Breakup by Product:

·         Dukoral

·         Shanchol

·         Vaxchora

·         Euvichol and Euvichol-Plus

·      Others
 

Breakup by End User:

·         Hospitals and Clinics

·         Research and Academic Laboratories

·         Others

 
Breakup by Region:

 
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/cholera-vaccines-market

 
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

 
Key highlights of the report:

 
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

 
About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

 
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

 
Contact Us:


IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

 

Top